Interleukin-6 Levels and Cardiovascular Events in the Cardiovascular Inflammation Reduction Trial: Consistent Associations for Incident Coronary, Cerebrovascular, and Peripheral Artery Disease

MLA

Lucas Marinho, et al. “Interleukin-6 Levels and Cardiovascular Events in the Cardiovascular Inflammation Reduction Trial: Consistent Associations for Incident Coronary, Cerebrovascular, and Peripheral Artery Disease.” JVS - Vascular Science, vol. 3, no. 419-, Jan. 2022. EBSCOhost, https://doi.org/10.1016/j.jvssci.2022.05.039.

APA

Lucas Marinho, Aaron W. Aday, Nancy R. Cook, Alan R. Morrison, Navneet Narula, Jagat Narula, Francesca Bartoli-Leonard, Elena Aikawa, Jocelyn M. Beach, Paul M. Ridker, & Aruna D. Pradhan. (2022). Interleukin-6 Levels and Cardiovascular Events in the Cardiovascular Inflammation Reduction Trial: Consistent Associations for Incident Coronary, Cerebrovascular, and Peripheral Artery Disease. JVS - Vascular Science, 3(419-). https://doi.org/10.1016/j.jvssci.2022.05.039

Chicago

Lucas Marinho, Aaron W. Aday, Nancy R. Cook, Alan R. Morrison, Navneet Narula, Jagat Narula, Francesca Bartoli-Leonard, et al. 2022. “Interleukin-6 Levels and Cardiovascular Events in the Cardiovascular Inflammation Reduction Trial: Consistent Associations for Incident Coronary, Cerebrovascular, and Peripheral Artery Disease.” JVS - Vascular Science 3 (419-). doi:10.1016/j.jvssci.2022.05.039.